* Ultralife Corp ULBI.OQ reported a quarterly adjusted loss
of 4 cents per share for the quarter ended in September. The
lone analyst forecast for the quarter was for earnings of 8
cents per share.
* Revenue was $21.76 million; analysts expected $27.00
million.
* Ultralife Corp's reported EPS for the quarter was a loss of 4
cents.
* The mean earnings estimate of analysts had fallen by
about 38.5% in the last three months.
* In the last 30 days one analyst negatively revised an earnings
estimate
* Ultralife Corp shares had fallen by 3.1% this quarter and
gained 6.6% so far this year.
* The company reported a quarterly loss of $585 thousand.
* Wall Street's median 12-month price target for Ultralife Corp
is $12.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated October 28 at 01:34 p.m.
All figures in US dollars unless otherwise stated